Sleep‐Deprivation Serum Induces Mitochondrial Stress in BV2 Cells: Responses to P2Y12 ‐Targeted Pharmacological Modulation
- 18 November 2026
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 40 (22)
Abstract
Sleep deprivation (SD) disrupts neuroimmune and metabolic homeostasis, but whether circulating factors generated after sleep loss alter microglial responses to purinergic pharmacological modulation remains unclear. P2Y12 is a microglia‐enriched purinergic receptor that regulates process dynamics, calcium signaling, and microglial interactions with neurons and vascular‐glial interfaces. Here, we established an in vitro serum‐transfer model to test whether serum from sleep‐deprived mice alters mitochondrial and Rhod‐2 fluorescence responses to P2Y12‐targeted compounds in BV2 cells. Mice were subjected to forced‐wheel SD consisting of one wheel revolution every 2 s for 4 h per day over 4 consecutive days, and serum was obtained by cardiac blood collection followed by centrifugation. BV2 cells were treated with control or SD serum in the absence or presence of the P2Y12 antagonist MRS2395 or the P2Y12 agonist 2‐MeSADP. Mitochondrial membrane potential was assessed by JC‐1 red/green ratio imaging, mitochondrial network integrity by MitoTracker‐based segmentation and skeletonization, and Rhod‐2 fluorescence responses by single‐cell F / F 0 imaging. SD serum decreased the JC‐1 ratio, increased maximal depolarization, reduced mitochondrial skeleton length and mitochondrial area fraction, and suppressed Rhod‐2 responses. Under control‐serum conditions, MRS2395 markedly enhanced Rhod‐2 responses, whereas the increase in the area under the Rhod‐2 response curve with 2‐MeSADP was not significant after Holm correction. Under SD‐serum conditions, however, neither compound consistently restored the mitochondrial or Rhod‐2 response profile. Together, these findings link SD‐serum exposure to mitochondrial impairment and attenuated Rhod‐2 fluorescence responses in BV2 cells, and suggest that serum context may influence cellular responses to P2Y12‐targeted compounds.Funding Information
- Natural Science Foundation of Shandong Province (ZR2023QC119)
- Shihezi University (IIT2025002)
- Science and Technology Bureau of Xinjiang Production and Construction Corps (2025DA055)
- National Natural Science Foundation of China (82401566)
- Postdoctoral Science Foundation of Hubei Province (2024HBBHCXA036)
This publication has 22 references indexed in Scilit:
- Microglial P2Y12 signaling phase-shifts glymphatic circadian rhythms and alters sleep architecture in miceProgress in Neurobiology, 2026
- Microglia synchronizes with the circadian rhythm of the glymphatic system and modulates glymphatic system functionIUBMB Life, 2024
- Microglia states and nomenclature: A field at its crossroadsNeuron, 2022
- Identification of a unique TGF-β–dependent molecular and functional signature in microgliaNature Neuroscience, 2013
- The microglial sensome revealed by direct RNA sequencingNature Neuroscience, 2013
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasomeNature Immunology, 2010
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010
- Sleep loss and inflammationBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- ATP mediates rapid microglial response to local brain injury in vivoNature Neuroscience, 2005
- Sleep-deprived mice show altered cytokine production manifest by perturbations in serum IL-1ra, TNFa, and IL-6 levelsBrain, Behavior, and Immunity, 2003